NINE75

NINE75 appears to be a small private healthcare and biopharma strategy consulting firm based in Seattle, Washington rather than a therapeutic developer. Publicly available evidence indicates the firm has provided strategic asset evaluation, business development transaction support, and general business operations support to biopharma companies. The company is associated with executives whose backgrounds span biopharma, medical devices, diagnostics, and healthcare operations, including prior experience at Bristol Myers Squibb and ZymoGenetics. There is no clear evidence that NINE75 operates a drug pipeline, develops proprietary therapeutics, or markets commercial healthcare products. Based on available sources, it is best characterized as an active boutique consulting company serving the healthcare and life sciences sector.